Stockscreener 앱 받기
1.11
0.00%
0.00
시간 외 거래:
1.10
-0.01
-0.90%
전일 마감가:
$1.11
열려 있는:
$1.15
하루 거래량:
45,183
Relative Volume:
0.32
시가총액:
$9.85M
수익:
$149.50K
순이익/손실:
$-6.96M
주가수익비율:
-0.8162
EPS:
-1.36
순현금흐름:
$-6.37M
1주 성능:
+2.78%
1개월 성능:
-16.54%
6개월 성능:
-33.93%
1년 성능:
-23.45%
1일 변동 폭
$1.07
$1.15
1주일 범위
$1.00
$1.16
52주 변동 폭
$0.9841
$2.55
Biorestorative Therapies Inc Stock (BRTX) Company Profile
명칭
Biorestorative Therapies Inc
전화
(631) 760-8100
주소
40 MARCUS DRIVE, MELVILLE
BRTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
1.11 | 9.85M | 149.50K | -6.96M | -6.37M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Biorestorative Therapies Inc 주식(BRTX)의 최신 뉴스
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Down 2.7%Time to Sell? - MarketBeat
How BioRestorative Therapies Inc. (9OF) stock trades in high volatility2025 Retail Activity & Stock Market Timing Techniques - Newser
Is BioRestorative Therapies Inc. (9OF) stock a buy on weakness2025 Key Highlights & AI Enhanced Trading Signals - Newser
Will BioRestorative Therapies Inc. (9OF) stock sustain dividend payoutsIPO Watch & Target Return Focused Picks - Newser
Will BioRestorative Therapies Inc. (9OF) stock sustain uptrend momentumMarket Trend Review & Reliable Entry Point Alerts - Newser
Why BioRestorative Therapies Inc. (9OF) stock could break out in 2025 - Newser
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Is BioRestorative Therapies Inc. stock vulnerable to regulatory risks2025 AllTime Highs & Risk Controlled Stock Pick Alerts - moha.gov.vn
BioRestorative Therapies’ Promising Study on BRTX-100 for Lumbar Disc Disease - MSN
BioRestorative Therapies (OTCMKTS:BRTX) Stock Crosses Below 50 Day Moving Average – Here’s Why - Defense World
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Can BioRestorative Therapies Inc. stock sustain revenue growth2025 Market WrapUp & Low Drawdown Investment Ideas - newser.com
What momentum indicators show for BioRestorative Therapies Inc. stock2025 Trading Volume Trends & AI Driven Stock Reports - newser.com
How BioRestorative Therapies Inc. (9OF) stock reacts to monetary easingEarnings Risk Summary & Low Drawdown Trading Strategies - newser.com
Will BioRestorative Therapies Inc. stock return to pre crisis levelsWeekly Gains Summary & High Conviction Buy Zone Picks - newser.com
Identifying reversal signals in BioRestorative Therapies Inc.2025 Investor Takeaways & Daily Price Action Insights - newser.com
Real time pattern detection on BioRestorative Therapies Inc. stockWeekly Market Outlook & Weekly Chart Analysis and Trade Guides - newser.com
How BioRestorative Therapies Inc. (9OF) stock reacts to fiscal policiesEarnings Performance Report & Daily Oversold Stock Bounce Ideas - newser.com
Published on: 2025-11-19 05:25:14 - newser.com
Why BioRestorative Therapies Inc. stock is recommended by analystsWeekly Trade Analysis & Scalable Portfolio Growth Ideas - newser.com
Chart overlay techniques for tracking BioRestorative Therapies Inc.2025 Breakouts & Breakdowns & Technical Pattern Based Signals - newser.com
What technical signals suggest for BioRestorative Therapies Inc. stockStop Loss & Free Weekly Watchlist of Top Performers - newser.com
BioRestorative Therapies (OTCMKTS:BRTXQ) Trading Up 6.4% – What’s Next? - Defense World
BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease - Ortho Spine News
Equities Analysts Offer Predictions for BRTX FY2025 Earnings - Defense World
BioRestorative Therapies, Inc. Secures Type B Meeting with FDA for Potential Accelerated BLA Approval of BRTX-100 for Chronic Lumbar Disc Disease - Quiver Quantitative
Biorestorative Therapies Inc (BRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.36%
1.12%
자본화:
|
볼륨(24시간):